Cancer clinical trials in the region Auvergne-Rhône-Alpes
323 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Prostate cancer
#NCT04585750
#2023-504251-27-00
Metastatic Castration-resistant
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Endometrial cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Lung cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Breast cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT04626635
#2022-501234-37-00
Metastatic
MSS/pMMR
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
None
1
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Centre Léon Bérard (Lyon)
Nuvalent Inc.
Phase 1 / Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Nuvalent Inc.
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT05706129
#2023-504254-35-00
Urothelial carcinoma
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA